Medi Assist Healthcare Services Limited has informed stock exchanges about the board approval for a merger between two of its wholly owned subsidiaries. The company filed the disclosure under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Merger Details and Structure

The Board of Directors approved the Scheme of Amalgamation of International Healthcare Management Services Private Limited (IHMS) with Mayfair Consultancy Services India Private Limited (MCSI) on February 06, 2026. Under this arrangement, IHMS will serve as the transferor company while MCSI will be the transferee company.

The board meeting commenced at 02:00 p.m. (IST) and concluded at 05:15 p.m. (IST) on February 06, 2026.

Financial Profile of Merging Entities

Both subsidiaries operate in the healthcare and insurance ecosystem, providing back-office, administrative, data processing, and consultancy services. The financial details as of March 31, 2025 show the scale of operations for both entities.

Strategic Rationale and Benefits

The merger aims to deliver multiple operational and financial benefits. The consolidation will enable seamless access to assets including intangible assets, licenses, and intellectual properties, leading to operational synergies and reduced overheads.

Key anticipated benefits include:

• Streamlined group structure with reduced legal and regulatory compliance requirements
• Cost savings through focused operational efforts and resource rationalization
• Efficient utilization of common resource pools across human resources, administration, finance, and technology functions
• Enhanced cash management and optimized deployment of financial resources for growth opportunities

Transaction Structure and Impact

The merger involves no cash consideration. Upon the scheme becoming effective, the entire share capital of IHMS held by Medi Assist Healthcare Services will be cancelled and extinguished without requiring surrender of shares. The investment in IHMS shares appearing in the parent company's books will stand cancelled automatically.

Since both entities are wholly owned subsidiaries and the parent company is not a direct party to the merger scheme, there will be no change in Medi Assist Healthcare Services' shareholding pattern. The transaction falls under related party provisions but is exempt under Regulation 23(5)(b) of SEBI Listing Regulations and does not require compliance with Section 188 of Companies Act, 2013 as per MCA General Circular No. 30/2014.

Medi Assist Healthcare Services Limited reported strong financial performance for Q3 and nine-month period FY26, achieving 24% year-on-year revenue growth and becoming debt-free from January 2026. Following the results announcement, the company has made available the audio recording of its earnings call held on February 09, 2026.

Strong Financial Performance and Debt-Free Achievement

The company demonstrated robust growth with operating revenue increasing 24.0% year-on-year for the nine-month period. EBITDA reached 21.7% (excluding Paramount), while standalone Paramount TPA showed remarkable improvement with margins expanding 557 basis points quarter-on-quarter.

The company achieved debt-free status by reducing debt from previous levels to ₹39.4 Cr as of December 2025, and completely eliminating debt from January 2026 onwards, strengthening its balance sheet position.

Market Share Expansion and Premium Growth

Medi Assist continued to expand its market presence with total Group and Retail premiums administered growing 21.9% year-on-year to ₹19,298.1 Cr. The company's market share of Group and Retail premiums under administration increased to 21.1%, representing an expansion of 133 basis points year-on-year.

The company processed 72.91 lakh claims during the period, including 17.22 lakh cashless inpatient claims, 9.80 lakh reimbursement inpatient claims, 18.22 lakh cashless outpatient claims, and 27.67 lakh reimbursement outpatient claims.

Technology Platform Performance

Medi Assist's proprietary technology offerings showed exceptional growth with revenues increasing 81.5% year-on-year. The company's AI-powered platforms continued to demonstrate strong performance across key metrics.

MAven Guard and Raksha Prime now integrate as add-ons with legacy and proprietary systems, including insurers' captive claims processing centres, expanding the company's reach across the ecosystem.

Earnings Call Recording and Regulatory Compliance

Pursuant to Regulation 30 and Regulation 46(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has made available the audio recording of its earnings call held on February 09, 2026. The call discussed the unaudited financial results for the quarter and nine months ended December 31, 2025.

The recording is accessible on the company's website, providing stakeholders with detailed insights into the financial performance and strategic developments discussed during the investor conference call.

Leadership Changes and Strategic Appointments

The Board appointed Ms. Sunita Rebecca Cherian as Additional Director (Non-Executive, Non-Independent Director) effective February 06, 2026. With over 30 years of experience across various functions, she will serve as Member of the Nomination & Remuneration Committee and Corporate Social Responsibility Committee.

Ms. Himani Atul Kapadia will complete her second and final term as Independent Director on March 14, 2026. The Board also approved the transfer of Paramount TPA business to Medi Assist TPA, effective February 1, 2026, ensuring operational continuity and seamless service delivery.